Results 241 to 243 of about 1,076,749 (243)

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Lancet, The, 2012
Jeffrey A Cohen, Alasdair J Coles, Douglas L Arnold   +2 more
exaly  

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Chemical Reviews, 2012
exaly  

Tests of the standard electroweak model in nuclear beta decay

Reviews of Modern Physics, 2006
exaly